Sussex Cancer Fund
Analysis
Sussex Cancer Fund is a registered charity in England and Wales, based in Brighton. It was registered in May 2012, 14 years ago. Its declared purposes cover general charitable purposes, education/training and the advancement of health or saving of lives, which this site groups under health and saving lives. Legally it is a charitable company (Companies House number 07963616). It says it makes grants to individuals, provides human resources and provides buildings/facilities/open space.
In the financial year ending March 2025, Sussex Cancer Fund reported income of £433k and spending of £441k, spending 102% of its income. Across the 5 years on record, from March 2021 to March 2025, income grew from £165k to £433k (+163%), an average of +27% a year. The sharpest change came in the year to March 2022, when income rose by 141%. Over the whole period it spent 105% of the income it received.
Among 24,651 England and Wales charities whose main cause is health and saving lives and that reported income, Sussex Cancer Fund sits at the 82nd percentile: it is larger than about 82% of them. Against every charity in England and Wales with reported income it ranks in the 89th percentile. Charities of a similar size with the same main cause include The Prompt Maternity Foundation (£433k), Torbay and South Devon NHS Charitable Fund (£433k) and King Edward VII School Swimming Pool Trust (£433k).
Income and spending
Where the income comes from
- Other 100%
In the charity's own words
To provide financial support for cancer research and for the provision, maintenance and replacement of facilities, equipment and buildings for the Radiotherapy and Oncology department at the Royal Sussex County Hospital, Brighton.
Similar-sized charities, same cause
| Charity | Location | Income |
|---|---|---|
| The Prompt Maternity Foundation | Bristol | £433k |
| Torbay and South Devon NHS Charitable Fund | Torquay | £433k |
| King Edward VII School Swimming Pool Trust | Sheffield | £433k |
| The Institute for Cancer Vaccines and Immunotherapy | London | £433k |